Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivacaftor in CF Homozygous for F508del
NCT00953706Phase 2Terminated
- Sponsor
- Vertex Pharmaceuticals
- Start
- Sep 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivacaftor in cystic fibrosis (CF), sponsored by Vertex Pharmaceuticals. Started Sep 2009; status: terminated.
02
Drugs
ivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00953706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00953706.